Emerging Policy Response Resources / Government & Legislative Affairs / Regulatory Affairs

Orthogonal, Kwame Ulmer on the Value of AdvaMed Membership

At AdvaMed, we’re proud to be recognized for our work on behalf of the medtech community – and we’re especially grateful when that recognition comes from respected voices like Kwame…

AdvaMed response letter to OMB’s RFI on deregulation, highlighting support for regulatory reform that fosters medical innovation and improved patient care, dated May 12, 2025.
Emerging Policy Response Resources / Government & Legislative Affairs

OMB Request for Information on Deregulation

A powerful op-ed from AdvaMed’s CEO explaining why tariffs could undermine U.S. medtech innovation, jobs, and patient care—and what must be done.

Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Tariffs

AdvaMed Testifies in U.S. Senate 

WASHINGTON – Today, President and CEO Scott Whitaker of AdvaMed, the Medtech Association, testified before the U.S. Senate Committee on Finance in its hearing focused on the impact of tariffs…